Pfizer Stocks Bounce 4% on Sure 2025 Outlook Regardless of $1B Affect
Pfizer (PFE, Monetary) has mentioned it expects its 2025 earnings and profits to compare marketplace consensus, even because it predicts this type of redesign of federal drug advantages will hit it with